Sepsis-induced brain dysfunction

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 2, 2013, Pages 211-221

  Adam, Nicolas ^a   Kandelman, Stanislas ^b   Mantz, Jean ^b   Chrétien, Fabrice ^c   Sharshar, Tarek ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b BEAUJON HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

delirium; sepsis; sepsis induced brain dysfunction; septic associated encephalopathy

Indexed keywords

ENOLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN S100B; TUMOR NECROSIS FACTOR ALPHA;

BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN CELL; BRAIN DYSFUNCTION; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL ACTIVATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; GLASGOW COMA SCALE; HUMAN; MICROGLIA; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PROGNOSIS; REVIEW; SCORING SYSTEM; SEDATION; SEPSIS; SIGNAL TRANSDUCTION;

BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES; BRAIN ISCHEMIA; COMA; DELIRIUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; MICROCIRCULATION; NEUROLOGIC EXAMINATION; OXIDATIVE STRESS; SEPSIS; WERNICKE ENCEPHALOPATHY;

EID: 84873900452     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.159     Document Type: Review

References (121)

1. Ebersoldt M, Sharshar T, Annane D. Sepsis-associated delirium. Intensive Care Med. 33(6), 941-950 (2007).
2. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304(16), 1787-1794 (2010).
3. Sharshar T, Porcher R, Siami S et al.; Paris-Ouest Study Group on Neurological Effect of Sedation (POSGNES). Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit. Care Med. 39(8), 1960-1967 (2011).
4. Tracey KJ. Reflex control of immunity. Nat. Rev. Immunol. 9(6), 418-428 (2009).
5. Thayer JF, Sternberg EM. Neural aspects of immunomodulation: focus on the vagus nerve. Brain Behav. Immun. 24(8), 1223-1228 (2010).
6. Johnston GR, Webster NR. Cytokines and the immunomodulatory function of the vagus nerve. Br. J. Anaesth. 102(4), 453-462 (2009).
7. Konsman JP, Kelley K, Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1? and inducible nitric oxide synthase in rat brain. Neuroscience 89(2), 535-548 (1999).
8. Ilyin SE, Gayle D, Flynn MC, Plata- Salam?n CR. Interleukin-1? system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-?, TGF-?1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia. Brain Res. Bull. 45(5), 507-515 (1998).
9. Pintado C, Revilla E, Vizuete ML et al. Regional difference in inflammatory response to LPS-injection in the brain: role of microglia cell density. J. Neuroimmunol. 238(1-2), 44-51 (2011).
10. Wong ML, Bongiorno PB, Rettori V, McCann SM, Licinio J. Interleukin (IL)-1b, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system during systemic inflammation: pathophysiological implications. Proc. Natl Acad. Sci. USA 94, 227-232 (1997).
11. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9(1), 46-56 (2008).
12. Hess DC, Thompson Y, Sprinkle A, Carroll J, Smith J. E-selectin expression on human brain microvascular endothelial cells. Neurosci. Lett. 213(1), 37-40 (1996).
13. Hess DC, Bhutwala T, Sheppard JC, Zhao W, Smith J. ICAM-1 expression on human brain microvascular endothelial cells. Neurosci. Lett. 168(1-2), 201-204 (1994).
14. Hofer S, Bopp C, Hoerner C et al. Injury of the blood brain barrier and up-regulation of icam-1 in polymicrobial sepsis. J. Surg. Res. 146(2), 276-281 (2008).
15. Omari KM, Dorovini-Zis K. CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium. J. Neuroimmunol. 134(1-2), 166-178 (2003).
16. Zhou H, Andonegui G, Wong CH, Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J. Immunol. 183(8), 5244-5250 (2009).
17. Wong ML, Bongiorno PB, al-Shekhlee A, Esposito A, Khatri P, Licinio J. IL-1 ?, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areas. Neuroreport 7(15-17), 2445-2448 (1996).
18. Freyer D, Manz R, Ziegenhorn A et al. Cerebral endothelial cells release TNF-? after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J. Immunol. 163(8), 4308-4314 (1999).
19. Handa O, Stephen J, Cepinskas G. Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am. J. Physiol. Heart Circ. Physiol. 295(4), H1712-H1719 (2008).
20. Matsumura K, Cao C, Ozaki M, Morii H, Nakadate K, Watanabe Y. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J. Neurosci. 18(16), 6279-6289 (1998).
21. Bohatschek M, Werner A, Raivich G. Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency. Exp. Neurol. 172(1), 137-152 (2001).
22. van den Boogaard M, Kox M, Quinn KL et al. Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit. Care 15(6), R297 (2011).
23. Taccone FS, Su F, Pierrakos C et al. Cerebral microcirculation is impaired during sepsis: an experimental study. Crit. Care 14(4), R140 (2010).
24. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Francoise G. The neuropathology of septic shock. Brain Pathol. 14(1), 21-33 (2004).
25. Bozza FA, Garteiser P, Oliveira MF et al. Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J. Cereb. Blood Flow Metab. 30(2), 440-448 (2010).
26. Esen F, Erdem T, Aktan D et al. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Crit. Care 9(1), R18-R23 (2005).
27. Esen F, Senturk E, Ozcan PE et al. Intravenous immunoglobulins prevent the breakdown of the blood-brain barrier in experimentally induced sepsis. Crit. Care Med. 40(4), 1214-1220 (2012).
28. Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D, Bennett ED. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin. Sci. 96(5), 461-466 (1999).
29. Sharshar T, Carlier R, Bernard F et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med. 33(5), 798-806 (2007).
30. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR. Am. J. Neuroradiol. 27(10), 2179-2190 (2006).
31. Yi X, Wang Y, Yu FS. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. Invest. Ophthalmol. Vis. Sci. 41(13), 4093-4100 (2000).
32. Nishioku T, Dohgu S, Takata F et al. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell. Mol. Neurobiol. 29(3), 309-316 (2009).
33. Flierl MA, Stahel PF, Touban BM et al. Bench-to-bedside review: burn-induced cerebral inflammation - a neglected entity? Crit. Care 13(3), 215 (2009).
34. Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-? causes an increase in blood-brain barrier permeability during sepsis. J. Med. Microbiol. 50(9), 812-821 (2001).
35. Berg RM, Moller K, Bailey DM. Neurooxidative- nitrosative stress in sepsis. J. Cereb. Blood Flow Metab. 31(7), 1532-1544 (2011).
36. Jacob A, Brorson JR, Alexander JJ. Septic encephalopathy: inflammation in man and mouse. Neurochem. Int. 58(4), 472-476 (2011).
37. Jacob A, Hack B, Chiang E, Garcia JG, Quigg RJ, Alexander JJ. C5a alters blood- brain barrier integrity in experimental lupus. FASEB J. 24(6), 1682-1688 (2010).
38. Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem. Int. 52(3), 447-456 (2008).
39. Comim CM, Vilela MC, Constantino LS et al. Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis. Intensive Care Med. 37(4), 711-718 (2011).
40. Barichello T, Fortunato JJ, Vitali AM et al. Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Crit. Care Med. 34(3), 886-889 (2006).
41. Barichello T, Machado RA, Constantino L et al. Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit. Care Med. 35(9), 2186-2190 (2007).
42. Semmler A, Hermann S, Mormann F et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J. Neuroinflammation 5, 38 (2008).
43. Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1? and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 23(3), 309-317 (2009).
44. Wong ML, Rettori V, al-Shekhlee A et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 2(5), 581-584 (1996).
45. Bi XL, Yang JY, Dong YX et al. Resveratrol inhibits nitric oxide and TNF-? production by lipopolysaccharide-activated microglia. Int. Immunopharmacol. 5(1), 185-193 (2005).
46. Gavillet M, Allaman I, Magistretti PJ. Modulation of astrocytic metabolic phenotype by proinflammatory cytokines. Glia 56(9), 975-989 (2008).
47. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol. 27(3), 325-355 (2003).
48. Chan JY, Chang AY, Wang LL, Ou CC, Chan SH. Protein kinase C-dependent mitochondrial translocation of proapoptotic protein Bax on activation of inducible nitric-oxide synthase in rostral ventrolateral medulla mediates cardiovascular depression during experimental endotoxemia. Mol. Pharmacol. 71(4), 1129-1139 (2007).
49. Li FC, Chan JY, Chan SH, Chang AY. In the rostral ventrolateral medulla, the 70-kDa heat shock protein (HSP70), but not HSP90, confers neuroprotection against fatal endotoxemia via augmentation of nitric-oxide synthase I (NOS I)/protein kinase G signaling pathway and inhibition of NOS II/peroxynitrite cascade. Mol. Pharmacol. 68(1), 179-192 (2005).
50. Korcok J, Wu F, Tyml K, Hammond RR, Wilson JX. Sepsis inhibits reduction of dehydroascorbic acid and accumulation of ascorbate in astroglial cultures: intracellular ascorbate depletion increases nitric oxide synthase induction and glutamate uptake inhibition. J. Neurochem. 81(1), 185-193 (2002).
51. d'Avila JC, Santiago AP, Amancio RT, Galina A, Oliveira MF, Bozza FA. Sepsis induces brain mitochondrial dysfunction. Crit. Care Med. 36(6), 1925-1932 (2008).
52. Messaris E, Memos N, Chatzigianni E et al. Time-dependent mitochondrialmediated programmed neuronal cell death prolongs survival in sepsis. Crit. Care Med. 32(8), 1764-1770 (2004).
53. Won SJ, Tang XN, Suh SW, Yenari MA, Swanson RA. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production. Ann. Neurol. 70(4), 583-590 (2011).
54. Maekawa T, Fujii Y, Sadamitsu D et al. Cerebral circulation and metabolism in patients with septic encephalopathy. Am. J. Emerg. Med. 9(2), 139-143 (1991).
55. Berg RM, Taudorf S, Bailey DM et al. Cerebral net exchange of large neutral amino acids after lipopolysaccharide infusion in healthy humans. Crit. Care 14(1), R16 (2010).
56. Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 267(11), 1503-1510 (1992).
57. Moller K, Strauss GI, Qvist J et al. Cerebral blood flow and oxidative metabolism during human endotoxemia. J. Cereb. Blood Flow Metab. 22(10), 1262-1270 (2002).
58. Sharshar T, Gray F, Lorin de la Grandmaison G et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362(9398), 1799-1805 (2003).
59. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 407(6805), 802-809 (2000).
60. Polito A, Brouland JP, Porcher R et al. Hyperglycaemia and apoptosis of microglial cells in human septic shock. Crit. Care 15(3), R131 (2011).
61. Villmann C, Becker CM. On the hypes and falls in neuroprotection: targeting the NMDA receptor. Neuroscientist 13(6), 594-615 (2007).
62. Wilson JX, Dragan M. Sepsis inhibits recycling and glutamate-stimulated export of ascorbate by astrocytes. Free Radic. Biol. Med. 39(8), 990-998 (2005).
63. Voigt K, Kontush A, Stuerenburg HJ, Muench-Harrach D, Hansen HC, Kunze K. Decreased plasma and cerebrospinal fluid ascorbate levels in patients with septic encephalopathy. Free Radic. Res. 36(7), 735-739 (2002).
64. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J. Neurosci. 16(3), 877-885 (1996).
65. Lemstra AW, Groen in't Woud JC, Hoozemans JJ et al. Microglia activation in sepsis: a case-control study. J. Neuroinflammation 4, 4 (2007).
66. Zhou H, Lapointe BM, Clark SR, Zbytnuik L, Kubes P. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J. Immunol. 177(11), 8103-8110 (2006).
67. van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 375(9716), 773-775 (2010).
68. Ho GJ, Drego R, Hakimian E, Masliah E. Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr. Drug Targets. Inflamm. Allergy 4(2), 247-256 (2005).
69. van Eijk MM, Roes KC, Honing ML et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 376(9755), 1829-1837 (2010).
70. Morandi A, Hughes CG, Girard TD, McAuley DF, Ely EW, Pandharipande PP. Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill. Chest 140(3), 580-585 (2011).
71. Cheret C, Gervais A, Lelli A et al. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J. Neurosci. 28(46), 12039-12051 (2008).
72. Stevens RD, Nyquist PA. Coma, delirium, and cognitive dysfunction in critical illness. Crit. Care Clin. 22(4), 787-804; abstract x (2006).
73. Kadoi Y, Saito S, Kunimoto F, Imai T, Fujita T. Impairment of the brain ?-adrenergic system during experimental endotoxemia. J. Surg. Res. 61(2), 496-502 (1996).
74. Kadoi Y, Saito S. An alteration in the ?-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit. Care Med. 24(2), 298-305 (1996).
75. Semmler A, Frisch C, Debeir T et al. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp. Neurol. 204(2), 733-740 (2007).
76. Freund HR, Ryan JA Jr, Fischer JE. Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann. Surg. 188(3), 423-430 (1978).
77. Basler T, Meier-Hellmann A, Bredle D, Reinhart K. Amino acid imbalance early in septic encephalopathy. Intensive Care Med. 28(3), 293-298 (2002).
78. Rosengarten B, Wolff S, Klatt S, Schermuly RT. Effects of inducible nitric oxide synthase inhibition or norepinephrine on the neurovascular coupling in an endotoxic rat shock model. Crit. Care 13(4), R139 (2009).
79. Burkhart CS, Siegemund M, Steiner LA. Cerebral perfusion in sepsis. Crit. Care 14(2), 215 (2010).
80. Kadoi Y, Goto F. Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally-induced septic shock in rats. Anesth. Analg. 99(1), 212-220 (2004).
81. Sharshar T, Gray F, Poron F, Raphael JC, Gajdos P, Annane D. Multifocal necrotizing leukoencephalopathy in septic shock. Crit. Care Med. 30(10), 2371-2375 (2002).
82. Annane D, Trabold F, Sharshar T et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am. J. Respir. Crit. Care Med. 160(2), 458-465 (1999).
83. Kumar V, Sharma A. Neutrophils: Cinderella of innate immune system. Int. Immunopharmacol. 10(11), 1325-1334 (2010).
84. Pandharipande PP, Sanders RD, Girard TD et al.; MENDS investigators. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit. Care 14(2), R38 (2010).
85. Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit. Care Med. 37(6), 2051-2056 (2009).
86. Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology 43(5), 1042-1044 (1993).
87. Ely EW, Inouye SK, Bernard GR et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286(21), 2703-2710 (2001).
88. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 27(5), 859-864 (2001).
89. Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann. Neurol. 58(4), 585-593 (2005).
90. De Jonghe B, Cook D, Griffith L et al. Adaptation to the Intensive Care Environment (ATICE): development and validation of a new sedation assessment instrument. Crit. Care Med. 31(9), 2344-2354 (2003).
91. van den Boogaard M, Pickkers P, Slooter AJ et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ 344, e420 (2012).
92. Nguyen DN, Spapen H, Su F et al. Elevated serum levels of S-100? protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit. Care Med. 34(7), 1967-1974 (2006).
93. Pfister D, Siegemund M, Dell-Kuster S et al. Cerebral perfusion in sepsis-associated delirium. Crit. Care 12(3), R63 (2008).
94. Piazza O, Russo E, Cotena S, Esposito G, Tufano R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br. J. Anaesth. 99(4), 518-521 (2007).
95. Grandi C, Tomasi CD, Fernandes K et al. Brain-derived neurotrophic factor and neuron-specific enolase, but not S100b, levels are associated to the occurrence of delirium in intensive care unit patients. J. Crit. Care 26(2), 133-137 (2011).
96. Consales G, De Gaudio AR. Sepsis associated encephalopathy. Minerva Anestesiol. 71(1-2), 39-52 (2005).
97. Morandi A, Gunther ML, Vasilevskis EE et al. Neuroimaging in delirious intensive care unit patients: a preliminary case series report. Psychiatry (Edgmont) 7(9), 28-33 (2010).
98. Morandi A, Rogers BP, Gunther ML et al.; VISIONS Investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae. The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study. Crit. Care Med. 40(7), 2182-2189 (2012).
99. Thi VA, Nordmann P, Landrieu P. Encephalopathy associated with severe bacterial infections: 'presuppurative encephalitis' or 'toxi-infectious disorder'? Rev. Neurol. (Paris) 158(6-7), 709-712 (2002).
100. Klein I, Iung B, Labreuche J et al.; IMAGE Study Group. Cerebral microbleeds are frequent in infective endocarditis: a case- control study. Stroke 40(11), 3461-3465 (2009).
101. Young GB, Bolton CF, Archibald YM, Austin TW, Wells GA. The electroencephalogram in sepsis-associated encephalopathy. J. Clin. Neurophysiol. 9(1), 145-152 (1992).
102. Ely EW, Truman B, Manzi DJ, Sigl JC, Shintani A, Bernard GR. Consciousness monitoring in ventilated patients: bispectral EEG monitors arousal not delirium. Intensive Care Med. 30(8), 1537-1543 (2004).
103. Zauner C, Gendo A, Kramer L et al. Impaired subcortical and cortical sensory evoked potential pathways in septic patients. Crit. Care Med. 30(5), 1136-1139 (2002).
104. Ely EW, Shintani A, Truman B et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291(14), 1753-1762 (2004).
105. Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275(6), 470-473 (1996).
106. Sprung CL, Peduzzi PN, Shatney CH et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit. Care Med. 18(8), 801-806 (1990).
107. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA. The encephalopathy associated with septic illness. Clin. Invest. Med. 13(6), 297-304 (1990).
108. Salluh JI, Soares M, Teles JM et al.; Delirium Epidemiology in Critical Care Study Group. Delirium epidemiology in critical care (DECCA): an international study. Crit. Care 14(6), R210 (2010).
109. Lin SM, Huang CD, Liu CY et al. Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients. J. Crit. Care 23(3), 372-379 (2008).
110. Pandharipande P, Jackson J, Ely EW. Delirium: acute cognitive dysfunction in the critically ill. Curr. Opin. Crit. Care 11(4), 360-368 (2005).
111. Girard TD, Jackson JC, Pandharipande PP et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit. Care Med. 38(7), 1513-1520 (2010).
112. Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 160(1), 50-56 (1999).
113. Boer KR, van Ruler O, van Emmerik AA et al.; Dutch Peritonitis Study Group. Factors associated with posttraumatic stress symptoms in a prospective cohort of patients after abdominal sepsis: a nomogram. Intensive Care Med. 34(4), 664-674 (2008).
114. Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit. Care 12(Suppl. 3), S3 (2008).
115. Spapen H, Nguyen DN, Troubleyn J, Huyghens L, Schiettecatte J. Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock. Crit. Care 14(2), R54 (2010).
116. Schelling G, Roozendaal B, Krauseneck T, Schmoelz M, De Quervain D, Briegel J. Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery. Ann. N. Y. Acad. Sci. 1071, 46-53 (2006).
117. Bellolio MF, Gilmore RM, Stead LG. Insulin for glycemic control in acute ischemic stroke. Cochrane Databse Syst rev. 9, CD005346 (2011).
118. Weberpals M, Hermes M, Hermann S et al. NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J. Neurosci. 29(45), 14177-14184 (2009).
119. Toklu HZ, Uysal MK, Kabasakal L, Sirvanci S, Ercan F, Kaya M. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. J. Surg. Res. 152(2), 238-248 (2009).
120. Avtan SM, Kaya M, Orhan N et al. The effects of hyperbaric oxygen therapy on blood-brain barrier permeability in septic rats. Brain Res. 1412, 63-72 (2011).
121. Wratten ML. Therapeutic approaches to reduce systemic inflammation in septic-associated neurologic complications. Eur. J. Anaesthesiol. Suppl. 42, 1-7 (2008).